Who Paid My Doc
Gerald Hale
Interventional Pain Medicine Tulsa, OK Doctor of Osteopathy
NPI 1962414904 CMS profile 134092
2448 E 81St St, Suite 363, Tulsa, OK 74137
General payments
$1,055
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Gerald Hale of Tulsa, OK is reported in the CMS Open Payments database as having received $1,055 across 25 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 25th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $20 | 1 | |
| 2021 | General | $192 | 8 | |
| 2020 | General | $62 | 4 | |
| 2019 | General | $781 | 12 |
Beside peers
- Gerald Hale
- Interventional Pain Medicine median
- Middle half of Interventional Pain Medicine
- National median
In program year 2025, general payments to Gerald Hale were reported at $0. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.
Show as a table
| Year | Gerald Hale | Interventional Pain Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $781 | $684 | $216–$2,079 | $163 |
| 2020 | $62 | $382 | $122–$1,109 | $114 |
| 2021 | $192 | $552 | $167–$1,554 | $132 |
| 2022 | $0 | $605 | $187–$1,924 | $149 |
| 2023 | $0 | $671 | $195–$1,915 | $160 |
| 2024 | $20 | $684 | $206–$1,837 | $164 |
| 2025 | $0 | $657 | $184–$1,753 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 17 billing codesPaid by Medicare
$6,478
Medicare patients
34
Services billed
66
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Depression | 32% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
25 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Interventional Pain Medicine in Oklahoma
Brandon Valantine
Interventional Pain Medicine · Oklahoma City, OK
Amer Nouh
Interventional Pain Medicine · Edmond, OK
Muhammad Maqbool
Interventional Pain Medicine · Tulsa, OK
Justin Porter
Interventional Pain Medicine · Oklahoma City, OK
Samuel Korbe
Interventional Pain Medicine · Tulsa, OK
Joshua Woolard
Interventional Pain Medicine · Edmond, OK
Related records
Interventional Pain Medicine in Oklahoma
Practitioners in the same specialty and state, ranked by reported value.
All Interventional Pain Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Oklahoma
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.